Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Science Advances
|
February 28, 2024
Stat5 induces androgen receptor (<i>AR</i>) gene transcription in prostate cancer and offers a druggable pathway to target AR signaling
Cristina Maranto, Lavannya Sabharwal, Vindhya Udhane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2018
STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair
Cristina Maranto, Vindhya Udhane, David T Hoang, et al.
Cancers
|
May 4, 2026
Clinical Validation of the Belay Ascent™ Test to Report on Chromosomal Arm-Level Aneuploidy and Gene-Level Copy Number Variants in Cerebrospinal Fluid Using Low-Pass Whole-Genome Sequencing
Qian Nie, Kala F Schilter, Alexandra Larson, et al.
Cancers
|
April 14, 2026
Clinical Utility of Belay Summit™ Cerebrospinal Fluid Test to Inform Diagnosis and Management of Central Nervous System Cancer-A Single Institution Case Series
Michael Youssef, Alexandra Larson, Vindhya Udhane, et al.
Cancers
|
January 28, 2026
Analytical Validation and Clinical Sensitivity of the Belay Summit™ 2.0 Cerebrospinal Fluid Liquid Biopsy Test-An Expanded Comprehensive Genomic Profiling Platform for Central Nervous System Malignancies
Sakshi Khurana, Viriya Keo, Alexandra Larson, et al.
Science Advances
|
September 15, 2021
NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancers
Yunguang Sun, Ning Yang, Fransiscus E Utama, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Science Advances
|
February 28, 2024
Stat5 induces androgen receptor (<i>AR</i>) gene transcription in prostate cancer and offers a druggable pathway to target AR signaling
Cristina Maranto, Lavannya Sabharwal, Vindhya Udhane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2018
STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair
Cristina Maranto, Vindhya Udhane, David T Hoang, et al.
Cancers
|
May 4, 2026
Clinical Validation of the Belay Ascent™ Test to Report on Chromosomal Arm-Level Aneuploidy and Gene-Level Copy Number Variants in Cerebrospinal Fluid Using Low-Pass Whole-Genome Sequencing
Qian Nie, Kala F Schilter, Alexandra Larson, et al.
Cancers
|
April 14, 2026
Clinical Utility of Belay Summit™ Cerebrospinal Fluid Test to Inform Diagnosis and Management of Central Nervous System Cancer-A Single Institution Case Series
Michael Youssef, Alexandra Larson, Vindhya Udhane, et al.
Cancers
|
January 28, 2026
Analytical Validation and Clinical Sensitivity of the Belay Summit™ 2.0 Cerebrospinal Fluid Liquid Biopsy Test-An Expanded Comprehensive Genomic Profiling Platform for Central Nervous System Malignancies
Sakshi Khurana, Viriya Keo, Alexandra Larson, et al.
Science Advances
|
September 15, 2021
NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancers
Yunguang Sun, Ning Yang, Fransiscus E Utama, et al.
Page
of 2